The transcription factors Nanog and Gata6 are critical to specify the epiblast versus primitive endoderm (PrE) lineages. However, little is known about the mechanisms that regulate the protein stability and activity of these factors in the developing embryo. Here we uncover an early developmental function for the Polycomb group member Bmi1 in supporting PrE lineage formation through Gata6 protein stabilization. We show that Bmi1 is enriched in the extraembryonic (endoderm [XEN] and trophectodermal stem [TS]) compartment and repressed by Nanog in pluripotent embryonic stem (ES) cells. In vivo, Bmi1 overlaps with the nascent Gata6 and Nanog protein from the eight-cell stage onward before it preferentially cosegregates with Gata6 in PrE progenitors. Mechanistically, we demonstrate that Bmi1 interacts with Gata6 in a Ring finger-dependent manner to confer protection against Gata6 ubiquitination and proteasomal degradation. A direct role for Bmi1 in cell fate allocation is established by loss-of-function experiments in chimeric embryoid bodies. We thus propose a novel regulatory pathway by which Bmi1 action on Gata6 stability could alter the balance between Gata6 and Nanog protein levels to introduce a bias toward a PrE identity in a cell-autonomous manner.
During early mouse development, the transition from morula to blastocyst around embryonic day 3.5 (E3.5) marks the onset of differentiation into the inner cell mass (ICM) and trophectoderm (TE) (Jedrusik et al. 2008; Rossant 2008) . At this stage, the ICM is heterogeneous and composed of pluripotent epiblast and extraembryonic primitive endoderm (PrE) progenitors, as revealed by a ''salt-andpepper'' distribution of the key epiblast (Nanog) and PrE (Gata6) markers at E3.75 (Koutsourakis et al. 1999; Chambers et al. 2003 Chambers et al. , 2007 Mitsui et al. 2003; Chazaud et al. 2006; Plusa et al. 2008; Silva et al. 2009 ). Compartmentalization of two distinct expression domains for Nanog and Gata6 is then achieved by cell sorting and apoptosis and strictly delineates the newly formed epiblast and PrE lineages (E4.5) (Plusa et al. 2008; Meilhac et al. 2009 ). These confined expression patterns are stably maintained in blastocyst-derived embryonic (ES) and extraembryonic endoderm (XEN) stem cells-two cell populations that retain the properties of the epiblast and PrE, respectively (Evans and Kaufman 1981; Martin 1981; Kunath et al. 2005; Rossant 2008 ). Prior to blastocyst formation, however, Nanog and Gata6 are seen to overlap in most cells from the eight-cell up to the morula stage. This early expression pattern is also characterized by highly dynamic and variable protein levels among blastomeres (Dietrich and Hiiragi 2007; Plusa et al. 2008) . How Nanog and Gata6 segregation is triggered and how their expression is stabilized in the epiblast and PrE progenitors remain largely unknown.
Epigenetic factors have emerged as key regulators of cell fate decisions during early development (Torres-Padilla et al. 2007 ). Among them, the Polycomb-repressive complexes PRC1 (Ring1A, Ring1B, Bmi1, and Mel18) and PRC2 (Ezh2, Suz12, and Eed) are known to maintain the earlydetermined gene expression patterns of key developmental regulators such as homeobox genes (Satijn and Otte 1999; van Lohuizen 1999) . In the early embryo, PRCs are involved in specifying epigenetic asymmetry between parental genomes (Arney et al. 2001; Santos et al. 2005; Puschendorf et al. 2008) . Loss-of-function studies also demonstrated a crucial role for these complexes in maintaining the integrity of ES cells in culture (Azuara et al. 2006; Boyer et al. 2006; Jorgensen et al. 2006; Leeb and Wutz 2007; Chamberlain et al. 2008; Endoh et al. 2008; van der Stoop et al. 2008) . Although Polycomb group members are dynamically expressed throughout preimplantation development (O'Carroll et al. 2001; Puschendorf et al. 2008) , their specific function in blastocyst lineage formation remains elusive. In this study, we identified a novel regulatory pathway that underlies cell fate allocation during early development. This process mechanistically links Bmi1 to the lineage-specific transcription factors Nanog and Gata6.
We show that Bmi1 is repressed by Nanog in ES cells and highly expressed in extraembryonic endoderm ([XEN] and trophectodermal [TS] ) stem cells where Nanog is not present. In vivo investigation of expression patterns by immunostaining and single-cell PCR analysis established that Bmi1 first overlaps with Nanog and Gata6 to then preferentially segregate alongside Gata6 in PrE progenitors. In the absence of Bmi1, PrE formation is severely impaired in a cell-autonomous manner, as demonstrated in vitro in chimeric embryoid bodies (EBs). Critically, we demonstrate that Bmi1 physically interacts with Gata6 in PrEderived XEN cells and controls its protein stability and resultant activity by inhibiting Gata6 ubiquitination and proteasome-mediated degradation. Collectively, these findings provide novel evidence to suggest how Bmi1 action on Gata6 stability could impact on cell fate decisions between epiblast and PrE lineages, most likely by altering the balance between Nanog and Gata6 protein levels in individual cells. Interestingly, Bmi1 also interacts with and maintains high Gata3 protein levels in TE-derived TS cells (Tanaka et al. 1998 ), suggesting a broader function for Bmi1 in extraembryonic lineage formation and/or maintenance.
Results

Bmi1 is a direct target of Nanog in pluripotent stem cells
To investigate a possible transcriptional link between Nanog and PRC members, we took advantage of genetically modified ES cell lines with distinct Nanog expression levels (Chambers et al. 2003 (Chambers et al. , 2007 . Quantitative RT-PCR (qRT-PCR) analysis was performed in control RCN(t), Nanog À/À RCNbH(t), and Nanog-overexpressing EF4 ES cells maintained in self-renewing conditions (Fig. 1A) . Among the PRC members analyzed, Bmi1 was uniquely identified as being expressed inversely to Nanog ( Fig. 1A ; data not shown). While detected at low levels in control cells, Bmi1 transcript was markedly up-regulated in RCNbH(t) cells and repressed in EF4 cells, suggesting that Nanog negatively controls Bmi1 expression in ES cells.
Eight putative Nanog-binding sites (BS) were identified across the Bmi1 locus based on the Nanog consensus sequence motif (Supplemental Fig. S1A; Mitsui et al. 2003) . Nanog occupancy was assessed at these sites by chromatin immunoprecipitation (ChIP)-qPCR in undifferentiated ES cells. Results showed high enrichment levels at BS1 located 4 kb upstream of the Bmi1 transcription start site in Nanog-expressing cells but not in Nanog À/À ES cells, as expected ( Fig. 1B; Supplemental Fig. S1B ). Gata6, a known Nanog target gene, was used as positive control in these experiments (Singh et al. 2007; Frankenberg et al. 2011) . To directly assess Nanog action on Bmi1 expression, a 1.9-kb fragment from the Bmi1 regulatory region spanning BS1 (Bmi1 Reg) was inserted into a pGL3 promoter vector, and the luciferase reporter construct was transfected into HEK293 cells. Cotransfection with Nanog significantly reduced Bmi1 Reg activity (Fig. 1C ). This repressive effect was abolished when BS1 was mutated (Bmi1 Reg MUT), demonstrating that Nanog represses Bmi1 expression via the identified binding site.
Bmi1 expression is mosaic among undifferentiated ES cells
Nanog is heterogeneously expressed within Oct3/4-positive ES cell cultures (Chambers et al. 2007; Singh et al. 2007) . A knock-in GFP/Nanog reporter line (TNG) revealed that ES cells oscillate between Nanog-low and Nanog-high states, with Nanog-low cells being more prone to differentiate (Chambers et al. 2007 ). Using the same TNG reporter line, we checked whether Bmi1 was predominantly present in primed, Nanog-low ES cells. Immunostaining revealed a mosaic expression pattern for Bmi1 within ES cell colonies. As illustrated in Figure 1D , low levels of Bmi1 protein were detected in a manner mutually exclusive to GFP/Nanog signals. This was confirmed at the mRNA level in FACSsorted GFP/Nanog-low and GFP/Nanog-high ES cell populations ( Fig. 1E ). In contrast to Nanog, Oct3/4 and Sox2 expression was equally high in both cell populations, highlighting the undifferentiated state of sorted cells ( Fig. 1F ; data not shown). Bmi1 transcript was consistently enriched in GFP/Nanog-low ES cells, with relatively lower levels being detected in the Nanog-high state (Fig. 1F ). These results indicate that Nanog dynamically regulates Bmi1 expression in pluripotent cells and further suggest that Bmi1 might be an early hallmark of differentiation.
Bmi1 is an early marker of extraembryonic endoderm cell commitment
Remarkably, however, Bmi1 was not up-regulated in all Nanog À/À RCNbH(t) ES cells (n = 61/265) (data not shown), but instead was selectively detected in a subset of cells that coimmunostained for Gata6 (n = 58/61, P < 0.01, Wilcoxon test) ( Fig. 1G ). This confined expression pattern was confirmed in tamoxifen-inducible Nanog À/À RCNbHB ES cells, where Bmi1 and Gata6 were promptly and simultaneously induced upon Nanog depletion, followed by Gata4 and Dab2-two late markers of the PrE lineage (Supplemental Fig. S2A ; Yang et al. 2002; Capo-Chichi et al. 2005 ). Colocalization of Bmi1, Gata6, and Gata4 protein in Nanog-depleted cells was verified by immunostaining (Supplemental Fig. S2B ), further pointing to a close association between Bmi1 up-regulation and the acquisition of an extraembryonic cell identity. Consistently, we found that Bmi1 was highly expressed in XEN cells as well as in TS cells-two stem cell populations derived from the PrE and TE lineages that lack Nanog, in contrast to ES cells (Supplemental Fig. S3 ). Taken together, these data demonstrate that Bmi1 is rapidly up-regulated in PrE-like cells upon Nanog depletion and suggest a role for Bmi1 in extraembryonic lineages.
Bmi1 is dynamically expressed alongside Nanog and Gata6 in vivo
To explore this function, we investigated Bmi1 expression profile alongside Nanog and Gata6 in the early developing embryo. Bmi1 is a maternally inherited factor that is highly expressed in cleavage stage embryos (Puschendorf et al. 2008) . Consistently, Bmi1 protein was homogeneously detected in all blastomeres of four-cell stage embryos ( Fig.  2A) . From eight-cell up to the early morula stage (20 cells, E3.0), Bmi1 overlapped in most cells with the nascent Figure 1 . Bmi1 is repressed by Nanog in ES cells and constitutes an early hallmark of extraembryonic differentiation. (A) Relative transcript levels for Nanog, Oct3/4, Bmi1, and Gata6 as assessed by qRT-PCR in control RCN(t), Nanog À/À RCNbH(t), and Nanogoverexpressing EF4 ES cells maintained in self-renewing conditions. Data were normalized to S17 and L19 and expressed relative to RCN(t) cells. Error bars represent the SD of three biological replicates. P-values were calculated using the Student's t-test. (B) Schematic representation of the Bmi1 locus (University of California at Santa Cruz Genome Browser NCBI37/mm9) showing Nanog putative binding sites (BS; top panel) and abundance of Nanog at the Bmi1 BS1 and Gata6 promoter in RCN(t), RCNbH(t), and EF4 ES cells (bottom panel). The arrow indicates the position of the Bmi1 transcription start site. The red line highlights a 1.9kb fragment from the Bmi1 regulatory region cloned into a pGL3 promoter vector for luciferase reporter assays as shown in C. Nanog enrichment levels were assessed by ChIP and qPCR and expressed relative to input. Unspecific immunoprecipitation was monitored by control IgG antibodies; background levels are denoted by dotted lines. Error bars represent the SD of three biological replicates. P-values were calculated using the Student's t-test. (C) Luciferase assay for Bmi1 regulatory region. HEK293T cells were transfected with the Bmi1 regulatory region containing Bmi1 BS1 (Bmi1 Reg; AATCCATTATG) or its mutated version (Bmi1 Reg MUT; AATCAGGCCTG) reporter constructs with or without Nanog. Luciferase activity was normalized to the control pGL3 promoter and Renilla. Error bars represent the SD of three biological replicates. P-values were calculated using the Student's t-test. (D) Example of Bmi1 and GFP/Nanog coimmunostaining in GFP/Nanog knock-in TNG ES cell colonies grown in self-renewing conditions. Bars, 10 mm. (E) GFP intensity profile of TNG ES cells as assessed by FACS analysis. Gates used for sorting are indicated. (F) Expression levels of GFP/Nanog, Oct3/4, Bmi1, and Gata6 as assessed in sorted GFP Low and GFP High TNG ES cells by qRT-PCR. Error bars represent the SD of three biological replicates. P-values were calculated using the Student's t-test. (G) Immunofluorescence analysis showing the colocalization of Bmi1 and Gata6 in a subset of Nanog À/À RCNbH(t) ES cells. Bars, 10 mm.
Nanog and Gata6 protein ( Fig. 2B ; data not shown). This pattern was dynamically altered around cavitation (E3.25), when cell heterogeneity arose among blastomeres. In particular, we observed the emergence of a subpopulation of cells (14.6%) that coexpress Bmi1 and Gata6 but not Nanog (29-to 43-cell embryos; P < 0.0001, Wilcoxon test) ( Fig. 2B ,C). Bmi1 protein staining became noticeably weaker in the developing blastocyst (E3.5-E4.5) (data not shown) despite Bmi1 transcript being detected throughout (see below), possibly reflecting a change in Bmi1 post-translational modifications (Voncken et al. 2005) . These data reveal a dynamic protein expression pattern for Bmi1 and confirm its close association with Gata6 in vivo.
Bmi1 preferentially cosegregates with Gata6 in PrE progenitors in the developing blastocyst
Single-cell PCR analysis was exploited to dissect RNA segregation events and further examine the relationship between Bmi1 and Gata6 expression during epiblast/PrE lineage specification. ICMs were isolated from blastocysts by immunosurgery and dissociated into single blastomeres. Embryos analyzed in these experiments were staged based on the average cell number scored among littermates. Bmi1 expression was then examined by qRT-PCR in each individual blastomere, alongside Gapdh, Gata6, Gata4, Nanog, and Ring1B (Fig. 3 ). In the early blastocyst (49-to 50-cell stage; E3.25), Gata6 and Nanog were expressed in most, if not all, ICM cells, with little variability between blastomeres (Fig. 3A, top panel) . Mutually exclusive expression of Gata6 and Nanog emerged at the 75-to 91-cell stage (E3.5) ( Fig. 3A , middle panel) and became more prominent at the 163-to 227-cell stage (E4.5) (Fig. 3A , bottom panel) (P < 0.05 at E3.5 and P < 0.01 at E4.5; Spearman test) ( Fig. 3B ), as previously reported (Kurimoto et al. 2006; Guo et al. 2010) . At these developmental stages, Gata6 expression was correlated with Gata4 (P < 0.05 at E3.25 and P < 0.01 at E3.5 and E4.5, Spearman test), denoting PrE lineage emergence and establishment within the ICM. Bmi1 expression was similarly detected in almost all ICM cells of the early blastocyst (E3.25), and its expression was gradually restricted to Gata6-positive/Nanog-negative, presumptive PrE cells ( Fig. 3A) . Remarkably, at E3.5 and E4.5, Bmi1 expression exhibited a significant correlation with Gata6 (P < 0.01, Spearman test) ( Fig. 3B ). In contrast, the expression of another PRC1 component, Ring1B, did not correlate with Gata6 in the late blastocyst (E4.5). These results establish that Bmi1 preferentially cosegregates with Gata6 at the transcript level in nascent PrE progenitors during blastocyst development.
Bmi1 is physically associated with Gata6 in extraembryonic XEN cells
The observed association between Bmi1 and Gata6 prompted us to investigate a possible transcriptional cross-regulation between the two factors. Ectopically expressing Bmi1 in ES cells did not, however, impact on Gata6 expression. Conversely, Gata6 overexpression, carried out as previously described (Fujikura et al. 2002; Shimosato et al. 2007) , only led to a slight increase in Bmi1 mRNA levels (data not shown), suggesting that no direct transcriptional cross-regulation operates between Bmi1 and Gata6. To test whether Bmi1 and Gata6 could be part of a same protein complex, Cos-7 cells were cotransfected with Gata6 and Bmi1, and cell lysates were subjected to anti-Gata6 immunoprecipitation. Bmi1 was strongly coimmunoprecipitated with Gata6, as revealed by anti-Bmi1 immunoblotting, thus demonstrating that Bmi1 and Gata6 are indeed physically associated (Supplemental Fig. S4A ). Importantly, we confirmed that endogenous Bmi1 and Gata6 protein can also be successfully coimmunoprecipitated with anti-Bmi1 ( Fig. 4A , top panel) or anti-Gata6 (Fig. 4A ,bottom panel) antibodies in XEN cells and furthermore found this association to be DNAindependent, as indicated by Benzonase treatment of the protein extracts (data not shown). In contrast, the Bmi1 paralog Mel18 failed to interact with Gata6 in parallel experiments, highlighting the specificity of Bmi1/Gata6 association (Supplemental Fig. S4B ). As expected, Bmi1 could readily interact with other core PRC1 members expressed in XEN cells, including Ring1B and Cbx8 (Supplemental Fig. S4C , left panels). However, Gata6 was not detected in the same complex (Supplemental Fig. S4C , right panels), further suggesting that Bmi1/Gata6 interaction might not take place in a canonical PRC1 complex.
Bmi1 stabilizes Gata6 protein levels and enhances its transcriptional activity
Critically, we next demonstrated that Bmi1/Gata6 association directly impacts on Gata6 stability and degradation in PrE derivatives. In this analysis, XEN cells were stably transfected with two shRNA vectors targeting Bmi1 (Supplemental Fig. S4D ,E). Gata6 protein levels were assessed in control (XEN Control ) and Bmi1 knockdown (XEN Bmi1KD ) XEN cells cultured for 0, 1, 2, and 4 h in the presence of cycloheximide (CHX). Without protein syn- thesis, Gata6 protein levels gradually decreased in control cells, with little or no effect on Gata6 transcription ( Fig.  4B ; data not shown). This trend was dramatically accelerated in the absence of Bmi1, suggesting that the Bmi1/ Gata6 interaction protects Gata6 from degradation. In contrast, no such difference was detected in Gata4 protein decay (Fig. 4B ), a factor that was not found to interact with Bmi1 by coimmunoprecipitation in XEN cells (data not shown). The addition of the proteasome inhibitor MG132 alongside CHX confirmed that Gata factor degradation was proteasome-dependent ( Fig. 4C ). Moreover, blocking ubiquitination with the E1 ubiquitin ligase inhibitor PYR41 also abolished Gata protein degradation ( Fig. 4D) , with Gata6 becoming detected in both the nucleus and cytosol of treated cells (Supplemental Fig. S4F ). A role for Bmi1 in regulating this process was then di-rectly validated by comparing the levels of Gata6 multiubiquitination (Ub) in XEN Control and XEN Bmi1KD cells following proteasome inhibition. The absence of Bmi1 resulted in an increased accumulation of Gata6 ubiquitinated forms (Fig. 4E ), which strictly mirrors its decreased protein stability (Fig. 4B ). Gata4's ubiquitination status remained unchanged, as expected ( Fig. 4E ). Interestingly, Bmi1-mediated Gata6 stabilization also enhanced the transcriptional activity of Gata6, as assessed by luciferase assays using a Gata6-dependent Hnf4 promoter reporter (Morrisey et al. 1998) in XEN cells in the presence or absence of Bmi1 (Fig. 4F ). Collectively, these results demonstrate that Bmi1/Gata6 association regulates Gata6 protein stability and enhances its transcriptional activity through the inhibition of Gata6 ubiquitination and proteasomemediated degradation. The C-terminal domain of Gata6 mediates its interaction with Bmi1 and ubiquitin-dependent degradation
In an attempt to establish which domain of Gata6 was critical for ubiquitin-dependent proteasome degradation, we next generated truncated Gata6 mutants lacking the C-terminal domain alone (DCT) or including its zinc finger region (DCTZF), where putative lysine ubiquitination sites are preferentially mapped (highlighted by asterisks in Fig. 5A ). Flag-tagged wild-type, DCT, or DCTZF Gata6 constructs were transfected into Cos-7 cells, and Gata6 protein decay and ubiquitination status were assessed as previously performed (Fig. 4 ). Both deletions resulted in an increased Gata6 protein stability (Fig. 5B ) and a reduced sensitivity to ubiquitination (Fig. 5C ), identifying the C-terminal domain as being critical for Gata6 degradation via ubiquitination. Moreover, this domain was found to be equally important for Gata6 interaction with Bmi1, as demonstrated by coimmunoprecipitation assays (Fig. 5D ). Conversely, using a similar mutagenesis approach for Bmi1, we validated that Bmi1/Gata6 interaction is mediated via the Bmi1 Ring finger domain ( Fig. 5E,F ; Hosokawa et al. 2006 ) and furthermore demonstrated that an intact Bmi1 is required for enhancing Gata6 transcriptional activity ( Fig. 5G ). Taken together, these results reiterate the functional importance of Bmi1/Gata6 interaction and further suggest how Bmi1 binding can confer protection against Gata6 ubiquitination and degradation, most likely by masking lysine residues in the Gata6 C-terminal domain from ubiquitin-conjugating enzymes.
Bmi1 promotes the emergence of PrE-like cells upon EB formation
The experiments described thus far show that Bmi1 cosegregates with Gata6 in PrE derivatives, where it interacts with and stabilizes Gata6 protein levels. This suggests an early developmental function for Bmi1 in regulating extraembryonic endoderm lineage formation that we investigated in ES-derived EBs. In this system, ES cells are induced to form aggregates in hanging drops, and differentiation is allowed to proceed over 5 d. During this time window, PrE-and epiblast-like cells first emerge in a saltand-pepper manner (Rula et al. 2007) . They then segregate with the formation of an organized, outer PrE-like layer that costains for Bmi1, Gata6, and Gata4, as visualized by immunofluorescence on day 5 EBs (Fig. 6A) . As previously reported, Nanog-overexpressing EBs were not capable of forming a proper outer layer (Chambers et al. 2003; Niakan et al. 2010) , and this phenotype was associated with a loss of Bmi1 induction alongside Gata6 and Gata4 (data not shown).
To directly assess the effect of Bmi1 depletion on this process, Bmi1 knockdown ES cells were established by stable transfection with different Bmi1 shRNA vectors. These cells showed no increased incidence of differentiation when grown in self-renewing conditions (data not shown). Importantly, Bmi1 knockdown was efficiently maintained upon EB formation, as assessed at the mRNA and protein levels ( Fig. 6B; data not shown) . Here, we observed a pronounced defect on PrE-like cell differentiation in the absence of Bmi1. While Oct3/4 and Nanog were down-regulated in both control and Bmi1 knockdown EBs, the induction of the PrE markers Gata6 and Sox17 was impaired (Fig. 6B) , with no proper outer layer organization (Fig. 6C ). This phenotype most closely resembles that of Gata6 À/À EBs but differs from that of Sox17 À/À EBs, in accord with Bmi1 action on Gata6 stability ( Fig. 4 ; Koutsourakis et al. 1999; Fujikura et al. 2002; Niakan et al. 2010; Artus et al. 2011 ). Moreover, and as shown in Figure 6C , only very few PrE-like, Bmi1-depleted cells emerged, and these cells expressed Gata4 protein alongside Gata6, further highlighting that the emergence of PrE-like progenitors, rather than their maturation, might be directly affected by Bmi1 depletion.
Bmi1 biases cell fate toward a PrE identity in a cell-autonomous manner
To assess whether the observed defect was cell-autonomous, we repeated these experiments and mixed control (ES Control ) cells with Bmi1 knockdown (ES Bmi1KD ) ES cells to form chimeric EBs. Cells were first labeled by stable Gfp transfection followed by FACS sorting, and the GFPlabeled ES Control or ES Bmi1KD cells aggregated with unlabeled ES Control cells upon EB formation (Fig. 6D ). The fate of labeled cells was assessed based on their position within the EB structure (inner/outer), and the emergence of PrE-like cells was monitored by looking at Gata6 expression ( Fig. 6E; Supplemental Fig. S5 ). Remarkably, GFP-ES Bmi1KD cells were preferentially located within the inner part of EBs (P < 0.05, Student's t-test) (Supplemental Fig. S5A ), in contrast to GFP-ES Control cells, which appeared to be evenly distributed. This observation was consistent with a lower frequency of Gata6-positive, GFP-ES Bmi1KD cells detected in day 5 EBs as compared with controls (P < 0.005, Student's t-test) (Supplemental Fig. S5B ). Taken together, these results demonstrate a direct role for Bmi1 in cell allocation between a PrE-and an epiblast-like fate upon EB formation.
Discussion
In this study, we identify a novel role for the Polycomb group member Bmi1 in regulating cell fate choice between extraembryonic endoderm and pluripotent lineages (Fig.  7) . We show that Bmi1 is readily detected in vivo in all blastomeres of cleavage stage embryos and overlaps with Nanog and Gata6 from the eight-cell stage onward. This pattern dynamically changes upon blastocyst formation, when Bmi1 becomes mosaic among ICM cells, preferentially cosegregating with Gata6 in nascent PrE progenitors. Critically, we demonstrate that Bmi1 controls Gata6 protein stability and its resultant activity by conferring protection against ubiquitination and proteasome-dependent degradation, as confirmed by Bmi1 knockdown in XEN cells. This effect is thought to be mediated through Bmi1/ Gata6 interaction via the Bmi1 Ring domain, which could, in turn, alter Gata6 protein conformation and/or mask lysine residues in the Gata6 C-terminal domain from Figure 5 . The C-terminal domain of Gata6 is critical to trigger its ubiquitin-dependent degradation and interacts with the Bmi1 Ring domain. (A) Scheme depicting Flag-tagged Gata6 wild-type and truncated forms. Wild-type Gata6 (Wt) mouse cDNA was flagged, and mutants lacking either the C-terminal domain (DCT) alone or including its zinc finger region (DCTZF) were generated by PCR-based mutagenesis. Asterisks highlight the location of putative ubiquitination lysine sites in Gata6 protein. (B) Comparative protein stability assay using wild-type (Wt) and mutant Gata6 forms. Cos-7 cells were transiently transfected with wild-type, DCT, or DCTZF Gata6. Flagged Gata6 protein levels were assessed by immunoblotting following CHX treatment for the indicated times. The amount of Gata6 protein was quantified using ImageJ software and normalized to Actin as shown in graphs. ubitiquin-conjugating enzymes (Clurman et al. 1996) . Importantly, we establish that Bmi1 plays a cell-autonomous role in promoting the induction of the PrE lineage, as assessed in vitro in chimeric EBs. In the context of the early embryo, Gata6 and Nanog expression is first stochastic (Dietrich and Hiiragi 2007) , and cell fate is thought to remain flexible (Yamanaka et al. 2010) . We propose here that Bmi1 action on Gata6 stability could directly alter the balance between Gata6 and Nanog protein levels in individual blastomeres and thus impact on cell fate decisions by introducing a bias toward a PrE identity. Interestingly, Gata4 does not interact with Bmi1, and this together with the late onset of Gata4 protein expression in vivo further suggests that Gata4 and Sox17 could, in turn, reinforce Gata6 function in a Bmi1-independent manner.
Interestingly, we provide novel evidence that Nanog represses Bmi1 in ES cells, as for Gata6 ( Fig. 7 ; Singh et al. 2007 ), further supporting the view that Nanog actively suppresses the PrE identity in pluripotent cells while being required for proper PrE differentiation in a non-cellautonomous manner Messerschmidt and Kemler 2010; Frankenberg et al. 2011) . We demonstrate that Bmi1 expression mirrors Nanog fluctuations within ES cell cultures and constitutes an early hallmark of extraembryonic differentiation upon Nanog depletion. Interestingly, while Bmi1 protein expression is mutually exclusive with Nanog, the Bmi1 transcript remained detected, although at variable levels, in Nanog-high and Nanog-low ES cell populations (Fig. 1 ), suggesting that Bmi1 itself may be post-transcriptionally regulated in this context. Several microRNAs were previously shown to target the Bmi1 39 untranslated region (UTR) in various cancer cell lines (Shimono et al. 2009 ). Here we identified miR-200c as being uniquely expressed in ES cells, as opposed to XEN and TS cells ( Supplemental Fig. S6A ), and positively regulated by Nanog ( Supplemental Fig. S6A,B) . Moreover, inhibiting miR-200c was found sufficient to release Bmi1 protein expression in ES cells (Supplemental Fig. S6C,D) , adding another level of Bmi1 expression control mediated by Nanog (Fig. 7) . Conversely, we found that ectopic expression of Bmi1 in ES cells reduces Nanog mRNA levels without altering Oct4, Sall4, or Klf4, yet is not capable of driving PrE differentiation alone (data not shown). Similar cross-regulatory events between Bmi1 and Nanog might also take place in vivo as Bmi1/Gata6 and Nanog transcripts segregate upon epiblast/PrE lineage specification, a pattern that is stably established in the late blastocyst by E4.5. By comparison, Bmi1 and Gata6 protein were seen to cosegregate in a subset of blastomeres in the early blastocyst around E3.25, suggesting that the Bmi1/Gata6 protein-protein interaction could be an early event in PrE emergence, while Nanog-mediated transcriptional repression of Bmi1, Gata6, and other factors would ''lock in'' or reinforce the epiblast/pluripotent identity both in vivo and in vitro. Additional mechanisms, such as the timing of cell internalization and signaling cascades, have also been shown to act in concert to dictate or consolidate PrE lineage specification Morris et al. 2010; Yamanaka et al. 2010) .
Bmi1 is a pleiotropic factor with roles linked to cell cycle regulation and cancer (Bruggeman et al. 2007; Grinstein and Mahotka 2009) as well as to the homeostasis of adult stem cells (van der Lugt et al. 1994; Molofsky et al. 2003; Park et al. 2003; Bruggeman et al. 2007 ). Our study unveils a previously unrecognized developmental function for Bmi1 (Puschendorf et al. 2008) , acting as a key posttranscriptional regulator of Gata6, a factor essential for extraembryonic endoderm development both in vitro and in vivo (Koutsourakis et al. 1999; Lim et al. 2008) . Of interest, Bmi1 was also found to interact with Gata3 in TEderived TS cells (Supplemental Fig. S7A ; Home et al. 2009; Ralston et al. 2010) . Bmi1 depletion in TS cells notably led to a loss of stem cell identity accompanied by a rapid and drastic reduction in Gata3 protein levels (Supplemental Fig. S7B-E ). This indicates that Bmi1 might regulate Gata3 protein expression in TS cells and suggests a broader role for Bmi1 in the formation and/or maintenance of extraembryonic lineages during early mouse development.
Materials and methods
Cell culture
Mouse ES, TS, and XEN cell lines were grown as previously described (Tanaka et al. 1998; Kunath et al. 2005; Alder et al. 2010) . For Nanog depletion, the RCNbHB cell line was treated with 1 mg/mL 49-OH-tamoxifen (Chambers et al. 2007 ). Transfections were carried out using Lipofectamine 2000 (Invitrogen, 11668) following the manufacturer's recommendations. For stable clone derivation, cells were treated 24 h post-transfection with puromycin (Sigma, p8833) at 1 mg/mL for 8-10 d. Clones were then pooled or picked individually, depending on the experimental design. EB formation was induced in hanging drops as previously described (Lavial et al. 2007 ).
Antibodies
Anti-Bmi1 (Millipore ,F6), anti-Gata6 (R&D Systems, AF1700), anti-Gata4 (Santa Cruz Biotechnology, sc-9053), anti-Gata3 Figure 7 . Model of Bmi1 function in extraembryonic endoderm lineage emergence. Nanog transcription factor protects the pluripotent state by repressing Bmi1 and Gata6 PrE-associated genes (depicted as black solid lines) and activating miR-200c, a microRNA also shown to modulate Bmi1 protein expression in ES cells (depicted as a black dotted line, indicating no evidence that this regulation is direct). (BS) Location of the Nanog-binding site upstream of the Bmi1 and miR-200c transcription start sites (arrows). Bmi1 physically interacts with and stabilizes Gata6 protein levels by protecting it from ubiquitination and proteasomal degradation (depicted as red triangles and dashed box). Formation of this complex enhances Gata6 transcriptional activity on target genes and promotes PrE emergence. Gata6 lies upstream of Gata4 and Sox17 in differentiation cascade (depicted as red dotted lines, indicating no evidence that these regulations are direct). Bmi1 expression also leads to a reduction in Nanog levels by an unknown mechanism (depicted as a black dotted line).
(Santa Cruz Biotechnology, sc-268), anti-Cdx2 (Biogenex, MU392A-UC), anti-Nanog (Cosmobio, RCA B000 2P-F), antiubiquitin (Biomol, FK2), anti-Ring1B (Active Motif, 39663), anti-Cbx8 (Bethyl Laboratories, A300-882A), anti-Mel18 (Abcam, ab5267), anti-GFP (Abcam, AB290), anti-Myc (Santa Cruz Biotechnology, sc-40), anti-Flag (Sigma, M2), and anti-Actin (Abcam, AB8227) were used. For immunoprecipitation experiments, anti-Gata6 (Santa Cruz Biotechnology, sc-9055) was used. For immunofluorescence, Alexa secondary antibodies were used (Invitrogen). For immunoblotting and coimmunoprecipitation experiments, mouse (Santa Cruz Biotechnology), rabbit (Santa Cruz Biotechnology), and goat (Dako) secondary antibodies were used.
RNA expression analysis
Total RNA was isolated using the Qiagen RNeasy minikit and DNase I-treated. Samples were oligo(dT) reverse-transcribed using Invitrogen SuperScript III or M-MLV following the manufacturer's recommendations and analyzed by qRT-PCR using Sigma Jumpstart SYBR Green. Primer sequences are available on request.
Vector construction
pLKO.1 vectors containing hairpins directed against Bmi1 cDNA were purchased from Sigma: shRNA vector 1 (CCGGCCAGCAA GTATTGTCCTATTTCTCGAGAAATAGGACAATACTTGCT GGTTTTT) and shRNA vector 2 (CCGGCCTGAACATAAG GTCAGATAACTCGAGTTATCTGACCTTATGTTCAGGTT TTT). The Bmi1 2.4-kb promoter was PCR-amplified on mouse ES cell genomic DNA using long expand Taq (Roche Biomedicals, 11681834001) and Bmi1prom-F (59-TCCCTGCCAGACT GTTTCTT-39) and Bmi1prom-R (59-CGTAAATGACCACGGG GATT-39) primers. Taq polymerase (Invitrogen 10342-020) was used to add adenines and clone the fragment into pGEMTeasy (Promega, TM042). The Bmi1 1.9-kb promoter fragment was then subcloned into the pGL3 promoter (Promega, E1761) using MluI and BglII restriction enzymes (New England Biolabs). Mutations in the Nanog-binding site BS1 were inserted by using PfuTurbo polymerase (Stratagene 600250), DpnI restriction enzyme (New England Biolabs), and Bmi1mut-F (59-TAAAATGTCTGGTCGC AGACTGCAATTGTCAGGCCTGATTAAGAGCGTACTTTAA GACAAATCACTT-39) and Bmi1mut-R (59-AAGTGATTTGTCT TAAAGTACGCTCTTAATCAGGCCTGACAATTGCAGTCTG CGACCAGACATTTTA-39) primers. Gata6 cDNA was subcloned in the BglII site of pSG5-Flag (Stratagene) using primers G6-F (59-ATAGATCTAGCCTTGACTGACGGCGGC-39) and G6-R (59-AT AGATCTATCAGGCCAGGGCCAGAGC-39). Gata6 truncated forms were generated with primers DCTZF-F (59-CCTGTCG GAGAGCCGCTGATAGATCTGGTACC-39), DCTZF-R (59-GGT ACCAGATCTATCAGCGGCTCTCCGACAGG-39), DCT-F (59-GG AATTCAAACCAGGAAACGAAAATGATAGATCTGGTACC ACTA-39), and DCT-R (59-TAGTGGTACCAGATCTATCATTT TCGTTTCCTGGTTTGAATTCC-39). Recombinant lentiviruses were generated using a three-plasmid system in 293T cells as previously described (Kutner et al. 2009 ). Virus-containing culture supernatants were collected 24 and 48 h after transfection, pooled, concentrated, and used for infection. Control and Bmi1KD-infected TS cells were collected 4 d post-infection as previously described (Alder et al. 2010) . The Gata6-dependent Hnf4 promoter was cloned into the pGL3 promoter as previously described (Morrisey et al. 1998 ). miR-200c inhibitor was purchased from Exiqon and transfected following the manufacturer's recommendations.
Luciferase reporter assay
Luciferase assays were carried out using 2.5 3 10 5 HEK293T cells in 96-well plates. Transfections with pGL3 promoter vectors and control peGFPC1 (Clontech) or pRenilla-Tk (Promega) were performed using Lipofectamine 2000 (Invitrogen, 11668-019). Luciferase activity was assessed 48 h post-transfection using a Steadylite kit (PerkinElmer, 6016756) following the manufacturer's recommendations. Transfection efficiency was corrected using GFP or Renilla levels.
Immunoblotting analysis
Cells lysis was carried out using RIPA buffer (50 mM Tris at pH 8, 1 mM EDTA, 0.5 mM EGTA, 1% Triton X-100, 0,1% sodium deoxycholate, 140 mM NaCl) supplemented with a protease inhibitor tablet (Roche Diagnostics, 11836153001). Protein fractionation was performed using NE-PER kit (Thermo Fisher Scientific, 78833) . Protein concentrations of whole-cell extracts were measured using a Bradford assay (Thermo Fisher Scientific, 23225). Thirty-microgram samples were loaded onto 10% acrylamide gels and blotted onto methanol-activated polyvinylidene fluoride membranes (Millipore, IPFL00010) using a semidry or wet transfer system. Membranes were treated with enhanced chemiluminescent substrate (Thermo Fisher Scientific, 32106).
ChIP and coimmunoprecipitation
ChIP was carried out as previously described (Alder et al. 2010) .
For coimmunoprecipitation experiments, 800 mg of cell protein extracts was precleared with protein A Sepharose beads (Sigma, P3391) for 2 h at 4°C and then incubated overnight at 4°C with the indicated antibodies. Protein A beads were then added for 5 h, washed with RIPA and TSE buffer (2 mM EDTA, 20 mM Tris at pH 8, 150 mM NaCl) four times, and loaded on either 7% or 14% acrylamide gels. Protein extracts were treated for 2 h at 4°C with 50 U of Benzonase (Merck, 71205) where indicated.
Protein stability assay
Cells were split, and 3 3 10 6 cells were plated back into 10-cm plates. On the following day, cells were treated with 100 mM CHX (Sigma), CHX plus 1 mM MG132 (Calbiochem, 474790), or CHX plus 1 mM PYR41 (Calbiochem, 662105) for the indicated times. Protein amounts were quantified using ImageJ software and normalized to Actin levels.
Ubiquitination assay
Cells were treated for 7 h with 1-5 mM MG132, lysed in the presence of deubiquitination inhibitor NEM (Sigma, E3876), sonicated, and subjected to overnight immunoprecipitation with control anti-IgG, anti-Gata6, anti-Gata4, or anti-Flag antibodies. Protein G beads (GE Healthcare, 17-0618-01) were added for 4 h at 4°C, and the levels of ubiquitination were subsequently revealed by immunoblotting with anti-ubiquitin antibody.
Immunofluorescence analysis
Cells were seeded on gelatinized glass coverslips and fixed in PBS with 4% paraformaldehyde. Samples were permeabilized and blocked at room temperature before incubation with the indicated antibodies. Coverslips were mounted on VectaShield with DAPI (Vector Laboratories, H-1200) and examined using a Leica SP5 confocal microscope (403 or 633 lens). Embryo immunostainings were performed as previously described (Chazaud et al. 2006) . EBs were fixed overnight in formalin at 4°C and embedded in agarose and wax. Five micromolar sections were used for stainings and observations on a Leica SP5 confocal microscope.
Embryo collection and staging for single-cell PCR analysis BL/6xC3H F1 mice were bred naturally, and the embryos were recovered at E3.25, E3.5, or E4.5 by flushing either the oviduct or uterus. ICMs were isolated from blastocysts by immunosurgery and further dissociated into single blastomeres by pipetting in a solution of 1 mM EDTA dissolved in HBS after treatment with 1% trypsin (Sigma, T-4549) and 1 mM EDTA in HBS. Staging of embryos subjected to single-cell PCR analysis was defined as follows. Upon recovery, average-size embryos were selected for subsequent analysis, and the remaining littermates were fixed in PBS with 4% paraformaldehyde (Electron Microscopy Sciences, 19208) and stained in PBS with 10 mM DAPI (Molecular Probes, D3571) and 5 U/mL Alexa Fluor 633 or Alexa Fluor 564 phalloidin (Molecular Probes, A22284 or A22283, respectively). Images were acquired on a Zeiss LSM 510 META or 710 microscope and analyzed using IMARIS software (Bitplane). The total cell number of each embryo was counted, and an average cell number of littermates (excluding those with maximum and minimum cell numbers) was used to define the developmental stage of each embryo processed for single-cell PCR analysis. Experiments were performed in accordance with European Union guidelines for the care and use of laboratory animals.
Single-cell cDNA amplification
Single-cell cDNA amplification from each blastomere was performed as previously reported (Kurimoto et al. 2006) . Briefly, single blastomeres were lysed in individual tubes without purification, and first strand cDNAs were synthesized using a modified poly(dT)-tailed primer. The unincorporated primer was specifically digested by exonuclease, and the second strands were generated with a second poly(dT)-tailed primer after poly(dA) tailing of the first strand cDNAs. The cDNAs were amplified by PCR first with poly(dT)-tailed primers and subsequently with primers bearing the T7 promoter sequence. The resultant cDNA products were used for further real-time PCR analysis. Primer sequences are available on request. Note that ''spike'' RNAs that consist of poly(A)-tailed RNAs artificially designed from Bacillus subtilis genes were added to each sample as amplification control to estimate the copy number of gene transcripts analyzed. A mixture of four distinct ''spike'' RNAs-Lys, Thr, Phe, and Dap (American Type Culture Collection 87482, 87483, 87484, and 87486)-were prepared so that each tube contained 1000, 100, 20, and five copies of each spike RNA, respectively.
Statistics analysis
Statistical analyses were performed using GraphPad Prism 5. For single-cell PCR analysis, the Spearman's rank correlation coefficient test was performed using R software to evaluate gene expression correlations with Gata6.
